EyePoint Pharmaceuticals Shares Fall After Diabetes Drug Fails to Meet Primary Endpoint-December 2024-www.financetom.com

EyePoint Pharmaceuticals Shares Fall After Diabetes Drug Fails to Meet Primary Endpoint

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

EyePoint Pharmaceuticals Shares Fall After Diabetes Drug Fails to Meet Primary Endpoint

May 6, 2024 5:53 AM

08:42 AM EDT, 05/06/2024 (MT Newswires) -- EyePoint Pharmaceuticals ( EYPT ) shares fell more than 26% in premarket activity Monday after the company said a trial of its potential diabetes treatment Duravyu failed to meet the primary endpoint of improvement of at least two levels on the Diabetic Retinopathy Severity Scale as of week 36.

Trading of the stock was briefly halted ahead of the Duravyu news release.

The trial of patients with non-proliferative diabetic retinopathy showed the drug has a "favorable safety and tolerability profile," the company said.

EyePoint said it plans to provide an update on a path forward for Duravyu following a full review of the phase 2 study data.

Price: 14.05, Change: -5.69, Percent Change: -28.82

Previous page： CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; CEO Marc Parent to Depart Next page： Market Chatter: Exxon Mobil to Sell Older Permian Basin Assets to Hilcorp for $1 Billion

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

CAE Fiscal Q2 Adjusted Earnings Fall, Revenue Rises; CEO Marc Parent to Depart

Nov 12, 2024

05:32 PM EST, 11/12/2024 (MT Newswires) -- CAE (CAE) reported fiscal Q2 adjusted earnings late Tuesday of 0.24 Canadian dollars ($0.17) per share, down from CA$0.26 a year earlier. Analysts polled by Capital IQ expected CA$0.18. Revenue for the quarter ended Sept. 30 rose to CA$1.14 billion from CA$1.05 billion a year earlier. Analysts surveyed by Capital IQ expected CA$1.09...

Market Chatter: Exxon Mobil to Sell Older Permian Basin Assets to Hilcorp for $1 Billion

Nov 12, 2024

10:45 AM EST, 11/12/2024 (MT Newswires) -- Exxon Mobil ( XOM ) has agreed to sell conventional oil-drilling assets in the Permian Basin to Hilcorp Energy for about $1 billion, Reuters reported Tuesday, citing four sources familiar with the matter. Exxon Mobil ( XOM ) and Hilcorp did not immediately respond to requests for comment from MT Newswires. (Market Chatter...

--Exxon Mobil to Sell Older Permian Basin Assets to Hilcorp for $1 Billion, Reuters Reports

Nov 12, 2024

10:45 AM EST, 11/12/2024 (MT Newswires) -- Price: 120.72, Change: +0.25, Percent Change: +0.20 ...

Ermenegildo Zegna Controlling Shareholder Buys Company Stock; Shares Rise

Nov 12, 2024

10:50 AM EST, 11/12/2024 (MT Newswires) -- Ermenegildo Zegna ( ZGN ) said Tuesday its controlling shareholder, Monterubello, has acquired 913,000 shares of the luxury company as of Monday. Monterubello plans to purchase 2 million additional Ermenegildo shares in the market in the coming weeks, the company said. Ermenegildo shares were up nearly 2.5% in recent Tuesday trading. Price: 7.47,...